江苏自贸试验区生物医药全产业链开放创新发展方案公布

Core Viewpoint - The State Council has approved the "Biopharmaceutical Industry Chain Open Innovation Development Plan" for the Jiangsu Free Trade Zone, aiming to enhance the biopharmaceutical sector's innovation and modernization by 2030 [1] Group 1: Key Tasks and Goals - The plan outlines 18 key tasks across 7 areas, focusing on improving biopharmaceutical R&D capabilities, product approval services, production and distribution systems, procurement policies, and support measures [1] - By 2030, the biopharmaceutical industry in the Jiangsu Free Trade Zone is expected to grow rapidly, optimize its innovation ecosystem, modernize its industrial chain, and significantly increase its openness [1] Group 2: Strategic Importance - The plan is a significant outcome of the strategy to enhance free trade zones, assigning new pilot reform tasks to the Jiangsu Free Trade Zone [1] - The Ministry of Commerce will collaborate with the Jiangsu provincial government and relevant departments to ensure the implementation of the plan and strengthen risk prevention in key areas [1]